NCT04276168

Brief Summary

In breast reduction surgery, delayed wound healing may increase surgical site infections, cutaneous necrosis and may be related to psychological harm.Some risk factors have been identified : smoking, diabetes, overweight. A normal healing involve cellular and biochemical reactions in which iron plays an important role such as cellular respiration, redox reactions and regulation of genes involved in the cell cycle. This trial will study the relationship between iron stores and postoperative wound healing after bilateral breast reduction surgery in patients without preoperative anaemia.The primary outcome of this trial is the comparison of wound healing at post operative day 15, between patients with and without iron deficiency.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 19, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2020

Completed
Last Updated

August 19, 2020

Status Verified

February 1, 2020

Enrollment Period

5 months

First QC Date

February 17, 2020

Last Update Submit

August 17, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of good breast tissue healing on each breast

    Good healing is defined as a score of 0, 1 or 2 on a 16 points-specifc scale. The scale evaluate proportion of disunity for periareolar vertical and horizontal incisions

    15 days after surgery

Secondary Outcomes (5)

  • Evaluation of healing on the 16 points specific scale

    15 days after surgery

  • Proportion of early complications

    up to 15 days after surgery

  • Proportion of closed drainage orifices

    15 days after surgery

  • Correlation between serum ferritin levels before surgery and score on the healing scale

    15 days after surgery

  • Intra-class correlation coefficient for the healing scale

    15 days after surgery

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cohort of woman who had a scheduled bilateral breast reduction surgery without anemia

You may qualify if:

  • age \>18 years
  • female
  • scheduled bilateral breast reduction surgery
  • biological exams with ferritin and transferrin saturation coefficient taken the day before surgery
  • No anemia : haemoglobin \>=12g/dL (preoperative biological assessment )
  • if genetic disease of haemoglobin, haemoglobin between 10 and 12g/dL and no Anaemia by iron deficiency
  • absence of clinical inflammatory syndrome (no clinical signs of infection or no fever)
  • non-opposition of the patient to participate

You may not qualify if:

  • Anaemia by iron deficiency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Louis hospital

Paris, France

Location

MeSH Terms

Conditions

Anemia, Iron-DeficiencySurgical Wound

Condition Hierarchy (Ancestors)

Anemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesWounds and Injuries

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2020

First Posted

February 19, 2020

Study Start

August 1, 2020

Primary Completion

December 15, 2020

Study Completion

December 15, 2020

Last Updated

August 19, 2020

Record last verified: 2020-02

Locations